Identifying advanced MAFLD in a cohort of T2DM and clinical features

BACKGROUND: MAFLD is the most common cause of chronic liver disease, affecting 25% of the global population. Patients with T2DM have an increased risk of developing MAFLD. In addition, patients with T2DM have a higher risk of advanced forms of steatohepatitis and fibrosis. Identifying those patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez-Bao, Ana Maria, Soto-Gonzalez, Alfonso, Delgado-Blanco, Manuel, Balboa-Barreiro, Vanesa, Bellido, Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992874/
https://www.ncbi.nlm.nih.gov/pubmed/36909342
http://dx.doi.org/10.3389/fendo.2023.1058995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992874/
https://www.ncbi.nlm.nih.gov/pubmed/36909342
http://dx.doi.org/10.3389/fendo.2023.1058995

Ejemplares similares